Bioceres Crop Solutions Corp.(BIOX)Earnings, Financials & Key Ratios
BIOX•NASDAQ
$0.36
Price updated Jul 6, 2026
AboutBioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through three segments: Seed and Integrated Products, Crop Protection, and Crop Nutrition. The Seed and Integrated Products segment develops and commercializes seed technology, biotechnological events, germplasm, and seed treatments. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. The company also offers HB4, a drought tolerant seed technology program. It operates in Argentina, Uruguay, France, South Africa, and internationally. The company was founded in 2001 and is headquartered in Rosario, Argentina. Bioceres Crop Solutions Corp. is a subsidiary of Bioceres LLC.Show more
- Revenue$333M-28.3%
- EBITDA$14M-79.3%
- Net Income-$52M-1697.3%
- EPS (Diluted)-0.82-1704.7%
- Gross Margin39.06%
- EBITDA Margin4.11%-71.1%
- Operating Margin-1.11%-111.5%
- Net Margin-15.54%-2327.5%
- ROE-16.02%-1784.4%
BIOX Price & Volume
Bioceres Crop Solutions Corp. (BIOX) stock price & volume — 10-year historical chart
Loading chart...
Persistent Revenue Contraction Strains Corporate Equity Base
Investment Thesis • Updated 2026Q2
VerdictNegative
Growth:Contracting
Profitability:Negative
Financial:Vulnerable
Cash Flow:Mixed
Primary Risk:Argentine macroeconomic volatility exposure
Key Thesis Takeaways
- Bioceres Crop Solutions faces significant headwinds as its core Argentine agricultural markets drive a 25.5% year-over-year revenue contraction observed in 2026Q2.
- The company's financial stability is increasingly compromised by an eroding equity base, which has plummeted from $314.0M in 2024Q4 to $73.8M in 2026Q2, alongside a debt-to-equity ratio that has surged to 2.25.
- Investors should remain cautious as the company struggles to achieve consistent operating leverage and faces potential liquidity constraints with a current ratio that has compressed to 0.90.
Verdict Logic
the company's current ratio of 0.90 and the rapid erosion of equity to $73.8M in 2026Q2 indicate substantial solvency risks that outweigh current operational performance.
BIOX Growth Metrics
Bioceres Crop Solutions Corp. (BIOX) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years14.1%
3 Years0.49%
TTM-28.69%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-15822.86%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-12974.39%
Return on Capital
10 Years14.04%
5 Years11.18%
3 Years7.04%
Last Year-0.78%
BIOX Recent Earnings
Bioceres Crop Solutions Corp. (BIOX) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 2/12 qtrs (17%)●Beat Revenue 2/12 qtrs (17%)
Q2 2026Latest
May 11, 2026Metric
Actual
Est
EPS
$0.16-220.0%
$0.05
Rev
$39M-27.7%
$55M
Q2 2026
Mar 13, 2026Metric
Actual
Est
EPS
$0.08-214.3%
$0.07
Rev
$74M-23.3%
$96M
Q4 2025
Nov 12, 2025Metric
Actual
Est
EPS
$0.12-200.0%
$0.04
Rev
$77M-14.2%
$90M
Q2 2025
May 21, 2025Metric
Actual
Est
EPS
$0.02+80.0%
$0.10
Rev
$60M-46.7%
$112M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 11, 2026 | $0.16vs $0.05-220.0% | $39Mvs $55M-27.7% |
| Q2 2026 | Mar 13, 2026 | $0.08vs $0.07-214.3% | $74Mvs $96M-23.3% |
| Q4 2025 | Nov 12, 2025 | $0.12vs $0.04-200.0% | $77Mvs $90M-14.2% |
| Q2 2025 | May 21, 2025 | $0.02vs $0.10+80.0% | $60Mvs $112M-46.7% |
Based on last 12 quarters of dataView full earnings history →
Peers Comparison
Key metrics vs top competitors for Bioceres Crop Solutions Corp. (BIOX)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $0.36 | $22.72M | -0.44 | -28.3% | -15.54% | -16.02% | — | |
| $5.60 | $1.68B | -3.97 | 146.73% | -646.99% | -1768.51% | — | |
| $11.38 | $1.42B | -0.64 | -18.34% | -72.93% | -82.27% | — | |
| $86.39 | $58B | 53.99 | 2.92% | 6.5% | 4.62% | — | |
| $3.11 | $88.96M | -1.78 | -5.88% | -8.71% | -21.86% | — | |
| $80.78 | $9.58B | 31.55 | 37.55% | 23.13% | 126.27% | — |
Compare BIOX vs Peers
Bioceres Crop Solutions Corp. (BIOX) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Get notified when BIOX posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
BIOX Frequently Asked Questions
Bioceres Crop Solutions Corp. (BIOX) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is Bioceres Crop Solutions Corp.'s revenue?
Bioceres Crop Solutions Corp. (BIOX) reported $285.1M in revenue for fiscal year 2025. This represents a 204% increase from $93.7M in 2017.
How fast is Bioceres Crop Solutions Corp. growing?
Bioceres Crop Solutions Corp. (BIOX) saw revenue decline by 28.3% over the past year.
Is BIOX profitable?
Bioceres Crop Solutions Corp. (BIOX) reported a net loss of $236.0M for fiscal year 2025.
Dividend & Returns
What is BIOX's return on equity?
Bioceres Crop Solutions Corp. (BIOX) has a return on equity (ROE) of -16.0%. Negative ROE indicates the company is unprofitable.
What is Bioceres Crop Solutions Corp.'s free cash flow?
Bioceres Crop Solutions Corp. (BIOX) generated $68.9M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.